Charles Sherwood
Vermögen: 59 255 $ am 31.07.2026
Vermögen: 59 255 $ am 31.07.2026
Charles Sherwood is currently Director at Vedanta Biosciences, Inc. and COO, Secretary & General Counsel at PureTech Health Plc since 2021.
Formerly, Mr. Sherwood was Vice President-Legal Counsel at Anika Therapeutics, Inc. Education includes graduate studies at Vanderbilt University and undergraduate studies at Middlebury College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PURETECH HEALTH PLC 0,02 % | 14.07.2026 | 37.001 ( 0,02 % ) | 59 255 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PURETECH HEALTH PLC | Geschäftsführer | 01.08.2021 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | General Counsel | 01.08.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
PureTech Health Plc
PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen